Warning: Undefined array key "mm" in /www/wwwroot/www.ai-bt.com/si.php on line 10 Deprecated: trim(): Passing null to parameter #1 ($string) of type string is deprecated in /www/wwwroot/www.ai-bt.com/si.php on line 10 Heparin-induced thrombocytopenia and thrombosis.

× No keyword cloud information.

18 in total

1. Treatment of the heparin-induced thrombosis-thrombocytopenia syndrome by very low dose streptokinase.

Authors: E Ferrari; P Morand; M Baudouy
Journal: Heart Date: 1996-08 Impact factor: 5.994

Review 2. Developments in antithrombotic therapy: state of the art anno 1996.

Authors: H ten Cate; M T Nurmohamed; J W ten Cate
Journal: Pharm World Sci Date: 1996-12

3. What's new about heparin-induced thrombocytopenia type II.

Authors: Yasser Sakr
Journal: Intensive Care Med Date: 2015-04-23 Impact factor: 17.440

4. Acute oxygenator failure: a new presentation of heparin-induced thrombocytopenia in a patient undergoing venovenous extracorporeal membrane oxygenation support.

Authors: Robert A Ratzlaff; Juan G Ripoll; Lena L Kassab; Jose L Diaz-Gomez
Journal: BMJ Case Rep Date: 2016-12-16

Review 5. Nadroparin calcium. A review of its pharmacology and clinical use in the prevention and treatment of thromboembolic disorders.

Authors: R Davis; D Faulds
Journal: Drugs Aging Date: 1997-04 Impact factor: 3.923

6. Anti-PF4/heparin antibodies are associated with arteriovenous fistula thrombosis in non-diabetic hemodialysis patients.

Authors: Yueh-Feng Tsai; Chien-An Chen; Chieh Kuo; Kao-Chang Lin
Journal: Clin Exp Nephrol Date: 2011-11-01 Impact factor: 2.801

Review 7. Glycoprotein IIb/IIIa inhibitor-induced thrombocytopenia: diagnosis and treatment.

Authors: S M Said; J Hahn; E Schleyer; M Müller; G M Fiedler; M Buerke; R Prondzinsky
Journal: Clin Res Cardiol Date: 2006-12-08 Impact factor: 5.460

Review 8. Anticoagulation for acute coronary syndromes and percutaneous coronary intervention in patients with heparin-induced thrombocytopenia.

Authors: K W Mahaffey
Journal: Curr Cardiol Rep Date: 2001-09 Impact factor: 2.931

9. Anti-platelet factor 4/heparin antibodies in orthopedic surgery patients receiving antithrombotic prophylaxis with fondaparinux or enoxaparin.

Authors: Theodore E Warkentin; Richard J Cook; Victor J Marder; Jo-Ann I Sheppard; Jane C Moore; Bengt I Eriksson; Andreas Greinacher; John G Kelton
Journal: Blood Date: 2005-08-18 Impact factor: 22.113

10. [Thrombocytopenia in a patient with coronary artery disease after percutaneous coronary intervention].

Authors: S M Said; R Prondzinsky
Journal: Internist (Berl) Date: 2008-05 Impact factor: 0.743